Lizhu Reagent's independently developed COVID-19 antigen detection kit has been approved. Self-testing can produce results in 15 minutes.
Published Time:
2022-04-14
On the evening of April 13, Joincare Pharmaceutical Group Industry Co., Ltd. announced that its subsidiary, Lizhu Group's holding subsidiary, Lizhu Reagent, has obtained the registration and listing approval from the National Medical Products Administration for its independently developed novel coronavirus (2019-nCoV) antigen detection kit (latex method). This novel coronavirus antigen detection kit (latex method) is applicable to three sample types: nasopharyngeal swabs, oropharyngeal swabs, and nasal swabs. The detection time is only 15 minutes. The operation is simple, the results are clear, and it is easy to interpret. It does not require a laboratory and can be used for self-testing.
With the rapid spread of Omicron, in accordance with epidemiological prevention and control requirements, rapid identification of infection sources requires simpler, easier, and more easily promoted detection technologies to adapt to the characteristics of the current variant's prevalence and to conduct large-scale rapid testing for more people. Currently on the market, self-testing antigen reagents with registered certificates have different methodologies, including fluorescence immunoassay, colloidal gold method, and latex method. Among them, fluorescence immunoassay requires additional equipment for interpretation and is basically unusable for self-testing; while the colloidal gold method and latex method do not require instruments and can be self-tested.
According to the introduction, Lizhu Reagent's self-developed novel coronavirus (2019-nCoV) antigen detection kit (latex method) has advantages over the colloidal gold method in detection: Firstly, it uses colored latex microspheres as signal markers. The latex microspheres have a uniform size and are 5-10 times larger than conventional colloidal gold particles, thus improving the detection sensitivity of the latex method. Secondly, carboxyl and other activating groups are incorporated into the colored latex microspheres during synthesis, and the labeled antibody and latex are covalently linked through chemical bonds, which is more stable than the charge connection between colloidal gold and protein.
In terms of specific advantages, this product is simple and easy to use, and rapid self-testing can be performed without any instruments or equipment, obtaining test results within 15-20 minutes. The product design is user-friendly, providing nasopharyngeal swabs, oropharyngeal swabs, and nasal swabs, as well as single-person/box, 5-person/box, and 20-person/box designs with multiple sample types, specifications, and components to meet different needs. 
More importantly, the product uses data from the domestic population in clinical trials, making it more suitable for the current domestic situation and resulting in more reliable results.
On March 10, the National Health Commission issued the "Application Plan for Novel Coronavirus Antigen Detection," proposing for the first time to "add antigen detection as a supplement to nucleic acid testing." In view of this, Lizhu Reagent accelerated relevant work according to the policy, under the guidance of Zhuhai Municipal Party Committee, Municipal Government, Xiangzhou District Party Committee, District Government, and drug regulatory authorities at all levels, completed the preparation of registration materials at the fastest speed, and submitted a registration application to the National Medical Products Administration on March 29, obtaining the registration certificate on April 12 [Product Name: Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Latex Method), Registration Certificate No.: Guo Xie Zhu Zhun 20223400470]. Prior to this, Lizhu Reagent's novel coronavirus antigen test kit had obtained EU CE, UK, Indonesian, and Thai registration certificates, as well as whitelist access qualifications in countries and regions such as France, Germany, and Austria, with products sold to multiple countries and regions in the EU and Asia-Pacific.
Lizhu Reagent's novel coronavirus (2019-nCoV) antigen detection kit (latex method) is used for in-vitro qualitative detection of novel coronavirus (2019-nCoV) N protein antigen. It can be used in medical institutions and for self-testing among quarantined personnel, close contacts, and community residents with self-testing needs, effectively alleviating domestic testing pressure and playing an important role in the early detection of novel coronavirus infection.
(This article does not constitute any investment advice; information disclosure is subject to the company's announcements. Investors operate at their own risk.)
Source: Daily Economic News